Understanding the influence of AMG 510 on the structure of KRASG12C empowered by molecular dynamics simulation.
Ontology highlight
ABSTRACT: The KRASG12C mutant is often associated with human cancers, and AMG 510 as a promising covalent inhibitor of KRASG12C has achieved surprising efficacy in clinical trials. However, the interaction mechanism between KRASG12C and AMG 510 is not completely understood. Here, we performed all-atom molecular dynamics simulations on the complex of KRASG12C-AMG 510 to explore the influence of this covalent inhibitor on the conformational change of KRASG12C. A PCA (Principal Component Analysis) model was constructed based on known KRAS crystal structures to distinguish different conformations (active, inactive, and other). By mapping simulation trajectories onto the PCA model, we observed that the conformations of KRASG12C bound with
SUBMITTER: Li Y
PROVIDER: S-EPMC8894142 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA